KeyBank National Association’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,477
Closed -$205K 957
2019
Q4
$205K Buy
+3,477
New +$189K ﹤0.01% 963
2019
Q2
Sell
-5,696
Closed -$281K 1010
2019
Q1
$281K Sell
5,696
-923
-14% -$41.8K ﹤0.01% 843
2018
Q4
$286K Sell
6,619
-86
-1% -$4.29K ﹤0.01% 801
2018
Q3
$381K Hold
6,705
﹤0.01% 840
2018
Q2
$338K Hold
6,705
﹤0.01% 848
2018
Q1
$334K Sell
6,705
-236
-3% -$11.1K ﹤0.01% 861
2017
Q4
$285K Sell
6,941
-422
-6% -$14.8K ﹤0.01% 905
2017
Q3
$219K Buy
7,363
+1,096
+17% +$33.5K ﹤0.01% 1016
2017
Q2
$208K Sell
6,267
-796
-11% -$25K ﹤0.01% 1046
2017
Q1
$209K Buy
+7,063
New +$193K ﹤0.01% 1079
2014
Q2
Sell
-7,828
Closed -$208K 1269
2014
Q1
$208K Buy
+7,828
New +$186K ﹤0.01% 1198

Other funds holding GMED

KeyBank National Association's GMED Position: Q1 2020 in Review

KeyBank National Association sold out of Globus Medical (GMED) in Q1 2020, closing a stake of 3,477 shares — an estimated $205K sold.

KeyBank National Association first reported a position in GMED in Q1 2014 and held it in 11 quarters. The position peaked at $381K in Q3 2018. 273 funds tracked by Wall St. Rank hold GMED as of Q1 2020.

  • KeyBank National Association reported no remaining Globus Medical position as of Q1 2020 after selling out during the quarter.
  • KeyBank National Association sold 3,477 Globus Medical shares in Q1 2020, an estimated $205K.
  • KeyBank National Association first reported a position in Globus Medical in Q1 2014 and held it in 11 quarters.
  • KeyBank National Association's Globus Medical position peaked at $381K in Q3 2018.
  • 273 funds tracked by Wall St. Rank held Globus Medical as of Q1 2020.

Based on KeyBank National Association's 13F filing for Q1 2020, filed 13 May 2020.